Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Verrucae treated by levamisole.

M Amer1, Z Tosson, A Soliman

  • 1Department of Dermatology and Venereology, Zagazig University, Faculty of Medicine, Egypt.

International Journal of Dermatology
|October 1, 1991
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Dynamic allele usage of X-linked genes ameliorates neurodevelopmental disease phenotypes in brain organoids.

Nature communications·2026
Same author

ECTOPIC THYROID PRESENTING AS MEDIASTINAL MASS.

Acta endocrinologica (Bucharest, Romania : 2005)·2025
Same author

Patient Experiences of Using Wearable Health Monitors During Cancer Treatment: A Qualitative Study.

Clinical oncology (Royal College of Radiologists (Great Britain))·2024
Same author

Response Letter to Laurelli et al. Letter to the Editor Regarding Enhancing Telemedicine to Improve Global Radiotherapy Access.

Clinical oncology (Royal College of Radiologists (Great Britain))·2024
Same author

Simultaneous implementation of unrelated tumour sites on the MR Linac: A review of the commissioning process from a radiographer perspective and lessons learned.

Journal of medical imaging and radiation sciences·2024
Same author

Expanding Global Radiotherapy Access via Telemedicine.

Clinical oncology (Royal College of Radiologists (Great Britain))·2024

Levamisole effectively treated common and plane warts in a study, demonstrating a 60% complete cure rate. However, it showed no significant improvement for plantar warts, indicating varied efficacy based on wart type.

Area of Science:

  • Dermatology
  • Immunology
  • Pharmacology

Background:

  • Warts are benign skin growths caused by human papillomavirus (HPV).
  • Current treatments for warts have variable efficacy and can cause side effects.
  • Levamisole, an immunomodulatory agent, has been explored for various dermatological conditions.

Purpose of the Study:

  • To evaluate the efficacy of levamisole in treating different types of warts.
  • To compare levamisole treatment with placebo in a double-blind study design.

Main Methods:

  • A double-blind, placebo-controlled study involving 40 patients with diverse wart types.
  • Patients were randomized into two groups: one receiving levamisole (5 mg/kg every 2 weeks for up to 5 months), the other receiving a placebo.
  • Treatment outcomes were assessed based on complete cure, partial cure, and no response.

Related Experiment Videos

Main Results:

  • Levamisole group: 60% complete cure, 10% partial cure, 30% no response.
  • Placebo group: Only one case achieved complete cure.
  • Higher efficacy observed for plane and common warts; plantar warts showed no improvement.

Conclusions:

  • Levamisole demonstrates significant efficacy in treating common and plane warts.
  • Plantar warts appear refractory to levamisole treatment.
  • Further research is warranted to explore levamisole's role in specific wart types and its immunomodulatory mechanisms.